Male reproductive metabolic syndrome: Redefining the "male PCOS equivalent" and its link to erectile dysfunction
-
-
REFERENCES
[1] Kurzrock R. and Cohen P. R. (2007). Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited. Med. Hypotheses 68:480−483. DOI:10.1016/j.mehy.2006.03.057 [2] Cannarella R., Condorelli R. A., Mongioi L. M., et al. (2018). Does a male polycystic ovarian syndrome equivalent exist. J. Endocrinol. Invest. 41:49−57. DOI:10.1007/s40618-017-0728-5 [3] di Clemente N., Racine C. and Rey R. A. (2022). Anti-mullerian hormone and polycystic ovary syndrome in women and its male equivalent. Biomedicines 10:2506. DOI:10.3390/biomedicines10102506 [4] Stener-Victorin E., Teede H., Norman R. J., et al. (2024). Polycystic ovary syndrome. Nat. Rev. Dis. Primers 10:27. DOI:10.1038/s41572-024-00511-3 [5] Xu H., Zhang M., Zhang H., et al. (2021). Clinical applications of serum anti-mullerian hormone measurements in both males and females: An update. The Innovation 2:100091. DOI:10.1016/j.xinn.2021.100091 [6] Myers S. H., Soulage C. O. and Unfer V. (2025). Endocrine metabolic syndrome and metabolic syndrome: Distinct but interrelated pathologies. Gynecol. Obstet. Invest. 20:1−11. DOI:10.1159/000545280 [7] Feng G., Xu H., Wan S., et al. (2024). Twelve practical recommendations for developing and applying clinical predictive models. Innov. Med. 2:100105. DOI:10.59717/j.xinn-med.2024.100105 [8] Xu H. Y., Zhang H. X., Xiao Z., et al. (2019). Regulation of anti-Mullerian hormone (AMH) in males and the associations of serum AMH with the disorders of male fertility. Asian J. Androl. 21:109−114. DOI:10.4103/aja.aja_83_18 [9] Xu H., Zeng L., Yang R., et al. (2017). Retrospective cohort study: AMH is the best ovarian reserve markers in predicting ovarian response but has unfavorable value in predicting clinical pregnancy in GnRH antagonist protocol. Arch. Gynecol. Obstet. 295:763−770. DOI:10.1007/s00404-016-4274-8 [10] Tal R., Seifer D. B., Khanimov M., et al. (2014). Characterization of women with elevated antimullerian hormone levels (AMH): Correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. Am. J. Obstet. Gynecol. 211:59 e51-58. DOI:10.1016/j.ajog.2014.02.026 -
ABOUT THIS ARTICLE
Cite this article:
Lin H., Zheng Z., Chen Q., et al. (2025). Male reproductive metabolic syndrome: Redefining the "male PCOS equivalent" and its link to erectile dysfunction. The Innovation Medicine 3:100144. https://doi.org/10.59717/j.xinn-med.2025.100144
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Lin H., Zheng Z., Chen Q., et al. (2025). Male reproductive metabolic syndrome: Redefining the "male PCOS equivalent" and its link to erectile dysfunction. The Innovation Medicine 3:100144. https://doi.org/10.59717/j.xinn-med.2025.100144
Format
Content
DownLoad:
-
Figure 1.
(A) Comparison of common PCOS and MRMS symptoms. (B) The comparison of age and AMH level between ED and infertility patients. (C) The proportion of ED and infertility in different AMH ranges. Data are represented as mean (SD).
